Quality of life and treatment-related burden during ocular proton therapy: a prospective trial of 131 patients with uveal melanoma

by Johannes Gollrad, Christopher Rabsahl, Aline-Isabel Riechardt, Jens Heufelder, Andrea Stroux, Ute Goerling, Antonia Joussen, Volker Budach, Dirk Boehmer
Published 2021-09-01

CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testing

by Lena Andersch, Josefine Radke, Anika Klaus, Silke Schwiebert, Annika Winkler, Elisa Schumann, Laura Grunewald, Felix Zirngibl, Carina Flemmig, Michael C. Jensen, Claudia Rossig, Antonia Joussen, Anton Henssen, Angelika Eggert, Johannes H. Schulte, Annette Künkele
Published 2019-09-01